
World - Medicaments Containing Hormones But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingMedicaments containing hormones market
Medicaments containing hormones market: download the latest info powered by an Ai-driven market research tool. Datasets provide market prices, imports, trade, market size, exports, consumption, companies, and production. There is a breakdown by region, including the U.K., the U.S., EU, Latin America, China, the Middle East, Russia, and Africa. Market trends and outlook to 2030 are also provided in the snapshots.
Medicaments Containing Hormones - World's Largest Markets
Rating | Country |
---|---|
1 | Iran |
2 | India |
3 | Germany |
4 | United States |
5 | China |
In value terms, Iran, India and Germany appeared to be the countries with the highest levels of market value in 2020, with a combined 25% share of the global market.
Among the main consuming countries, India saw the highest growth rate of market size, over the period under review, while medicaments containing hormones market for the other global leaders experienced more modest paces of growth.
Medicaments Containing Hormones Prices
Lowest Prices - FOB - Top Exporters
COUNTRY | 2018 | 2019 | 2020 | CAGR, 2018-2020 |
---|---|---|---|---|
USD per ton | ||||
Pakistan | 9041 | 9362 | 8120 | -5.2% |
Kuwait | 7265 | 8835 | 10230 | 18.7% |
Indonesia | 11393 | 11835 | 12165 | 3.3% |
United Kingdom | 26383 | 21936 | 16318 | -21.4% |
Ireland | 30452 | 33585 | 28976 | -2.5% |
United States | 32312 | 37074 | 42193 | 14.3% |
Netherlands | 23745 | 53769 | 58636 | 57.1% |
Poland | 116957 | 106242 | 120954 | 1.7% |
Average | 39032 | 37749 | 33247 | -7.7% |
Prices varied noticeably by the country of origin; the country with the highest price was Poland ($120,954 per ton), while Pakistan ($8,120 per ton) was amongst the lowest.
From 2018 to 2020, the most notable rate of growth in terms of prices was attained by the Netherlands (+57.1% per year), while the other global leaders experienced more modest paces of growth.
Highest Prices - CIF - Top Importers
COUNTRY | 2018 | 2019 | 2020 | CAGR, 2018-2020 |
---|---|---|---|---|
USD per ton | ||||
Belgium | 113558 | 130730 | 459961 | 101.3% |
Germany | 240594 | 236414 | 329667 | 17.1% |
Ireland | 199117 | 193117 | 234018 | 8.4% |
Denmark | 127882 | 142203 | 121212 | -2.6% |
Hungary | n/a | n/a | 77177 | 0.0% |
Poland | 64070 | 74814 | 62344 | -1.4% |
Nigeria | 17431 | 27932 | 26027 | 22.2% |
Namibia | 19079 | 15662 | 21535 | 6.2% |
United Kingdom | 19127 | 18590 | 18908 | -0.6% |
Malaysia | 18405 | 13608 | 16251 | -6.0% |
Spain | 16623 | 15500 | 15775 | -2.6% |
Afghanistan | 19461 | 13762 | 13658 | -16.2% |
Saudi Arabia | 31270 | 23217 | 10438 | -42.2% |
Average | 56199 | 62181 | 100135 | 33.5% |
There were significant differences in the average prices amongst the major importing countries. In 2020, the country with the highest price was Belgium ($459,961 per ton), while Saudi Arabia ($10,438 per ton) was amongst the lowest.
From 2018 to 2020, the most notable rate of growth in terms of prices was attained by Belgium (+101.3% per year), while the other global leaders experienced more modest paces of growth.
Medicaments Containing Hormones - Top Importers
COUNTRY | 2018 | 2019 | 2020 | CAGR, 2018-2020 |
---|---|---|---|---|
million USD | ||||
Belgium | 2.9 | 2.1 | 585 | 1312.3% |
Germany | 24 | 44 | 219 | 203.9% |
Denmark | 101 | 113 | 159 | 25.3% |
Ireland | 106 | 71 | 82 | -12.3% |
Poland | 11 | 7.9 | 66 | 147.1% |
In value terms, Belgium ($585M) constitutes the largest market for imported medicaments containing hormones but not antibiotics worldwide, comprising 39% of global imports. The second position in the ranking was occupied by Germany ($219M), with a 15% share of global imports. It was followed by Denmark, with a 11% share.
In Belgium, medicaments containing hormones imports increased at an average annual rate of +1,312.3% over the period from 2018-2020. The remaining importing countries recorded the following average annual rates of imports growth: Germany (+203.9% per year) and Denmark (+25.3% per year).
Medicaments Containing Hormones - Top Exporters
COUNTRY | 2018 | 2019 | 2020 | CAGR, 2018-2020 |
---|---|---|---|---|
million USD | ||||
Ireland | 18 | 13 | 536 | 452.8% |
United States | 166 | 176 | 179 | 3.9% |
Poland | 12 | 22 | 67 | 134.8% |
Netherlands | 2.8 | 16 | 42 | 285.5% |
Kuwait | 6.7 | 19 | 21 | 78.4% |
In value terms, Ireland ($536M) emerged as the largest medicaments containing hormones supplier worldwide, comprising 49% of global exports. The second position in the ranking was occupied by the United States ($179M), with a 16% share of global exports. It was followed by Poland, with a 6.1% share.
From 2018 to 2020, the average annual rate of growth in terms of value in Ireland amounted to +452.8%. The remaining exporting countries recorded the following average annual rates of exports growth: the United States (+3.9% per year) and Poland (+134.8% per year).
Medicaments Containing Hormones - Market Forecast
Driven by increasing demand for medicaments containing hormones worldwide, the market is expected to continue an upward consumption trend over the next decade. Market performance is forecast to decelerate, expanding with an anticipated CAGR of for the period from 2020 to 2030, which is projected to bring the market volume to by the end of 2030.
Medicaments Containing Hormones - Product Coverage
- HS 300339 - Medicaments; containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale
This report provides an in-depth analysis of the global medicaments containing hormones market. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201250 - Medicaments containing hormones but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale (excluding insulin)
Country coverage:
Worldwide - the report contains statistical data for 200 countries and includes detailed profiles of the 50 largest consuming countries:
- USA
- China
- Japan
- Germany
- United Kingdom
- France
- Brazil
- Italy
- Russian Federation
- India
- Canada
- Australia
- Republic of Korea
- Spain
- Mexico
- Indonesia
- Netherlands
- Turkey
- Saudi Arabia
- Switzerland
- Sweden
- Nigeria
- Poland
- Belgium
- Argentina
- Norway
- Austria
- Thailand
- United Arab Emirates
- Colombia
- Denmark
- South Africa
- Malaysia
- Israel
- Singapore
- Egypt
- Philippines
- Finland
- Chile
- Ireland
- Pakistan
- Greece
- Portugal
- Kazakhstan
- Algeria
- Czech Republic
- Qatar
- Peru
- Romania
- Vietnam
+ the largest producing countries
Data coverage:
- Global market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Global production, split by region and country
- Global trade (exports and imports)
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND THE AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional EditionPRO
3. MARKET OVERVIEW
Understanding the Current State of The Market and its Prospects
- MARKET SIZE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- CONSUMPTION BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- MARKET FORECAST TO 2035
4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION
Finding New Products to Diversify Your Business
- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCTS
- MOST TRADED PRODUCTS
- MOST PROFITABLE PRODUCTS FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Export
- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- PRODUCTION BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
- EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
-
11. COUNTRY PROFILES
The Largest Markets And Their Profiles
This Chapter is Available Only for the Professional Edition PRO- United States
- China
- Japan
- Germany
- United Kingdom
- France
- Brazil
- Italy
- Russian Federation
- India
- Canada
- Australia
- Republic of Korea
- Spain
- Mexico
- Indonesia
- Netherlands
- Turkey
- Saudi Arabia
- Switzerland
- Sweden
- Nigeria
- Poland
- Belgium
- Argentina
- Norway
- Austria
- Thailand
- United Arab Emirates
- Colombia
- Denmark
- South Africa
- Malaysia
- Israel
- Singapore
- Egypt
- Philippines
- Finland
- Chile
- Ireland
- Pakistan
- Greece
- Portugal
- Kazakhstan
- Algeria
- Czech Republic
- Qatar
- Peru
- Romania
- Vietnam
LIST OF TABLES
- Key Findings In 2024
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Per Capita Consumption, by Country, 2022–2024
- Production, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Import Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Export Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
LIST OF FIGURES
- Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
- Consumption, by Country, 2024
- Market Volume Forecast to 2035
- Market Value Forecast to 2035
- Market Size and Growth, By Product
- Average Per Capita Consumption, By Product
- Exports and Growth, By Product
- Export Prices and Growth, By Product
- Production Volume and Growth
- Exports and Growth
- Export Prices and Growth
- Market Size and Growth
- Per Capita Consumption
- Imports and Growth
- Import Prices
- Production, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Production, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Production, by Country, 2024
- Production, In Physical Terms, by Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Physical Terms, By Country, 2024
- Imports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Imports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Import Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Physical Terms, By Country, 2024
- Exports, In Physical Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Exports, In Value Terms, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
- Export Prices, By Country: Historical Data (2012–2024) and Forecast (2025–2035)
This report provides an in-depth analysis of the global medicaments containing hormones market.
This report provides an in-depth analysis of the global market for other medicaments for therapeutic or prophylactic uses.
This report provides an in-depth analysis of the global market for medicaments of alkaloids or derivatives thereof.
This report provides an in-depth analysis of the global market for medicaments of other antibiotics.
This report provides an in-depth analysis of the global medicaments containing insulin market.
This report provides an in-depth analysis of the global medicaments containing penicillin market.
Discover the top import markets for medicaments containing hormones, including Belgium, Denmark, United States, and more. Learn about the key players in the global market for hormone medications.
Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.
Discover the top countries by import value of non-penicillin or streptomycin antibiotic medicaments in 2023. Explore key statistics and market insights.
Pharmaceutical companies are fiercely competing in the obesity drug market, with Eli Lilly and Novo Nordisk among the major players. Innovations and collaborations are key in this dynamic and lucrative sector.
Novo Holdings finalizes $16.5 billion acquisition of Catalent, enhancing pharmaceutical capabilities amidst regulatory clearance.